21 February 2017
News and Views
Links and Services
The latest issue of the Alimentary Pharmacology & Therapeutics reviews the safety of rapid infliximab infusions.
Infliximab is typically administered intravenously via 2- to 3-hour duration infusions.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors